TY  - GEN
AU  - Li,Nan
AU  - Zhang,Cheng-Xiang
AU  - Wang,Xiao-Xing
AU  - Zhang,Liang
AU  - Ma,Xu
AU  - Zhou,Jia
AU  - Ju,Rui-Jun
AU  - Li,Xiu-Ying
AU  - Zhao,Wei-Yu
AU  - Lu,Wan-Liang
TI  - Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways
SN  - 1878-5905
PY  - 2013///0814
KW  - Adenosine Triphosphate
KW  - metabolism
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Caspases
KW  - Cell Death
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Cytochromes c
KW  - Drug Delivery Systems
KW  - Drug Resistance, Neoplasm
KW  - Enzyme Activation
KW  - Epirubicin
KW  - Female
KW  - Humans
KW  - Indazoles
KW  - Liposomes
KW  - chemistry
KW  - Membrane Potential, Mitochondrial
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mitochondria
KW  - Myeloid Cell Leukemia Sequence 1 Protein
KW  - Neoplasms
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Reactive Oxygen Species
KW  - Signal Transduction
KW  - Xenograft Model Antitumor Assays
KW  - bcl-2-Associated X Protein
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.biomaterials.2013.01.055
ER  -